BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38561565)

  • 21. [Max test verify further clinical research for whether individualized symptom-limited cardiopulmonary exercise testing is the maximum extreme exercise].
    Zhang Y; Sun XG; Liu F; Hao L; Song Y; Tai WQ; Ge WG; Li H; Shi C; Xu F; Wang JN; Zhang YF; Zhou QQ; Chen R; Zou YX; Ma MX; Xia R; Huang Y; Xie YH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Mar; 37(2):147-153. PubMed ID: 34672152
    [No Abstract]   [Full Text] [Related]  

  • 22. Reference Values for Cardiorespiratory Fitness in Patients Aged 6 to 18 Years.
    Griffith GJ; Wang AP; Liem RI; Carr MR; Corson T; Ward K
    J Pediatr; 2024 Jan; 264():113770. PubMed ID: 37802386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-processing Peak Oxygen Uptake Data Obtained During Cardiopulmonary Exercise Testing in Individuals With Spinal Cord Injury: A Scoping Review and Analysis of Different Post-processing Strategies.
    Alrashidi AA; Nightingale TE; Bhangu GS; Bissonnette-Blais V; Krassioukov AV
    Arch Phys Med Rehabil; 2023 Jun; 104(6):965-981. PubMed ID: 36584803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
    Jost J; Völker K; Brandt R; Stummer W; Urbschat S; Ketter R; Wiewrodt D; Wiewrodt R;
    J Neurooncol; 2024 May; 168(1):35-45. PubMed ID: 38561565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy.
    Klassen O; Schmidt ME; Scharhag-Rosenberger F; Sorkin M; Ulrich CM; Schneeweiss A; Potthoff K; Steindorf K; Wiskemann J
    Acta Oncol; 2014 Oct; 53(10):1356-65. PubMed ID: 24837860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the maximal cardiopulmonary exercise test in adolescents with major depressive disorder and comparison of cardiorespiratory fitness with sex- and age-related control values.
    Wenzel C; Bongers BC; Schlagheck ML; Reis D; Reinhard F; Schmidt P; Bernitzki S; Oberste M; Wunram HL; Zimmer P; Fricke O
    Eur J Pediatr; 2024 Jan; 183(1):379-388. PubMed ID: 37906306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Smartwatch-Based Heart Rate and Physical Activity With Cardiorespiratory Fitness Measures in the Community: Cohort Study.
    Zhang Y; Wang X; Pathiravasan CH; Spartano NL; Lin H; Borrelli B; Benjamin EJ; McManus DD; Larson MG; Vasan RS; Shah RV; Lewis GD; Liu C; Murabito JM; Nayor M
    J Med Internet Res; 2024 Jun; 26():e56676. PubMed ID: 38870519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiopulmonary Exercise Testing in a Prospective Multicenter Cohort of Older Adults: The Study of Muscle, Mobility and Aging (SOMMA).
    Wolf C; Blackwell TL; Johnson E; Glynn NW; Nicklas B; Kritchevsky SB; Carnero EA; Cawthon PM; Cummings SR; Toledo FGS; Newman AB; Forman DE; Goodpaster BH
    medRxiv; 2023 Sep; ():. PubMed ID: 37808837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience.
    Jost J; Müther M; Brandt R; Altuner U; Lemcke L; Stummer W; Völker K; Wiewrodt R; Wiewrodt D
    J Neurooncol; 2023 Jun; 163(2):367-376. PubMed ID: 37306887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and feasibility of cardiopulmonary exercise testing in head and neck cancer survivors.
    Midgley AW; Levy AR; Cunha FA; Key A; Patterson JM; Rogers SN
    Clin Physiol Funct Imaging; 2023 May; 43(3):170-180. PubMed ID: 36533848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical fitness and its association with fatigue in patients with low-grade glioma.
    van Coevorden-van Loon EMP; Horemans HHLD; Heijenbrok-Kal MH; van den Berg-Emons RJG; Rozenberg R; Vincent AJPE; Ribbers GM; van den Bent MJ
    Disabil Rehabil; 2023 Oct; 45(20):3323-3329. PubMed ID: 36148487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical functional capacity of patients with glioma prior to adjuvant radiation: preliminary descriptive study.
    Dulfikar A; Koh ES; Lwin Z; Hovey E; Dhillon H; Arundell J; Pinkham E; Pinkham MB; Holland J; Trajano G; Naumann F
    Neurooncol Pract; 2021 Jun; 8(3):290-298. PubMed ID: 34055376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review.
    Sandler CX; Matsuyama M; Jones TL; Bashford J; Langbecker D; Hayes SC
    J Neurooncol; 2021 May; 153(1):1-14. PubMed ID: 33907968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients and carers' perspectives of participating in a pilot tailored exercise program during chemoradiotherapy for high grade glioma: A qualitative study.
    Halkett GKB; Cormie P; McGough S; Zopf EM; Galvão DA; Newton RU; Nowak AK
    Eur J Cancer Care (Engl); 2021 Sep; 30(5):e13453. PubMed ID: 33877719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
    Weller M; van den Bent M; Preusser M; Le Rhun E; Tonn JC; Minniti G; Bendszus M; Balana C; Chinot O; Dirven L; French P; Hegi ME; Jakola AS; Platten M; Roth P; Rudà R; Short S; Smits M; Taphoorn MJB; von Deimling A; Westphal M; Soffietti R; Reifenberger G; Wick W
    Nat Rev Clin Oncol; 2021 Mar; 18(3):170-186. PubMed ID: 33293629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up.
    Roth P; Pace A; Le Rhun E; Weller M; Ay C; Cohen-Jonathan Moyal E; Coomans M; Giusti R; Jordan K; Nishikawa R; Winkler F; Hong JT; Ruda R; Villà S; Taphoorn MJB; Wick W; Preusser M; ;
    Ann Oncol; 2021 Feb; 32(2):171-182. PubMed ID: 33246022
    [No Abstract]   [Full Text] [Related]  

  • 37. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
    Herrlinger U; Tzaridis T; Mack F; Steinbach JP; Schlegel U; Sabel M; Hau P; Kortmann RD; Krex D; Grauer O; Goldbrunner R; Schnell O; Bähr O; Uhl M; Seidel C; Tabatabai G; Kowalski T; Ringel F; Schmidt-Graf F; Suchorska B; Brehmer S; Weyerbrock A; Renovanz M; Bullinger L; Galldiks N; Vajkoczy P; Misch M; Vatter H; Stuplich M; Schäfer N; Kebir S; Weller J; Schaub C; Stummer W; Tonn JC; Simon M; Keil VC; Nelles M; Urbach H; Coenen M; Wick W; Weller M; Fimmers R; Schmid M; Hattingen E; Pietsch T; Coch C; Glas M;
    Lancet; 2019 Feb; 393(10172):678-688. PubMed ID: 30782343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise Training in Cancer Control and Treatment.
    Christensen JF; Simonsen C; Hojman P
    Compr Physiol; 2018 Dec; 9(1):165-205. PubMed ID: 30549018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise Testing in Sports Medicine.
    Löllgen H; Leyk D
    Dtsch Arztebl Int; 2018 Jun; 115(24):409-416. PubMed ID: 29968559
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.